27491778|t|Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: underlying mechanisms. A double blind, randomized, placebo controlled trial
27491778|a|In heart failure patients the consumption of (-)-epicatechin ((-)-Epi)-rich cocoa can restore skeletal muscle (SkM) mitochondrial structure and decrease biomarkers of oxidative stress. However, nothing is known about its effects on exercise capacity and underlying mechanisms in normal, sedentary subjects. Twenty normal, sedentary subjects (∼50 years old) were randomized to placebo or dark chocolate (DC) groups and consumed 20 g of the products for 3 months. Subjects underwent before and after treatment, bicycle ergometry to assess VO2 max and work, SkM biopsy to assess changes in mitochondrial density, function and oxidative stress and blood sampling to assess metabolic endpoints. Seventeen subjects completed the trial. In the DC group (n = 9), VO2 max increased (17% increase, p = 0.056) as well as maximum work (watts) achieved (p = 0.026) with no changes with placebo (n = 8). The DC group evidenced increases in HDL levels (p = 0.005) and decreased triglycerides (p = 0.07). With DC, SkM evidenced significant increases in protein levels for LKB1, AMPK and PGC1α and in their active forms (phosphorylated AMPK and LKB1) as well as in citrate synthase activity while no changes were observed in mitochondrial density. With DC, significant increases in SkM reduced glutathione levels and decreases in protein carbonylation were observed. Improvements in maximum work achieved and VO2 max may be due to DC activation of upstream control systems and enhancement of SkM mitochondria efficiency. Larger clinical studies are warranted to confirm these observations.
27491778	22	36	dark chocolate	T168	UMLS:C3853217
27491778	71	79	subjects	T098	UMLS:C2349001
27491778	106	118	double blind	T062	UMLS:C0013072
27491778	120	130	randomized	T062	UMLS:C0034656
27491778	132	150	placebo controlled	T062	UMLS:C1706408
27491778	151	156	trial	T062	UMLS:C0008976
27491778	160	173	heart failure	T038	UMLS:C0018801
27491778	187	198	consumption	T038	UMLS:C1947907
27491778	202	217	(-)-epicatechin	T103	UMLS:C1881340
27491778	219	226	(-)-Epi	T103	UMLS:C1881340
27491778	233	238	cocoa	T168	UMLS:C0009209
27491778	251	266	skeletal muscle	T017	UMLS:C0242692
27491778	268	271	SkM	T017	UMLS:C0242692
27491778	273	286	mitochondrial	T017	UMLS:C0026237
27491778	287	296	structure	T082	UMLS:C0678594
27491778	310	320	biomarkers	T201	UMLS:C0005516
27491778	324	340	oxidative stress	T038	UMLS:C0242606
27491778	454	462	subjects	T098	UMLS:C2349001
27491778	489	497	subjects	T098	UMLS:C2349001
27491778	519	529	randomized	T062	UMLS:C0034656
27491778	533	540	placebo	T058	UMLS:C0032042
27491778	544	558	dark chocolate	T168	UMLS:C3853217
27491778	560	562	DC	T168	UMLS:C3853217
27491778	619	627	Subjects	T098	UMLS:C2349001
27491778	655	664	treatment	T058	UMLS:C0087111
27491778	666	683	bicycle ergometry	T058	UMLS:C0857787
27491778	694	701	VO2 max	T033	UMLS:C0429693
27491778	712	722	SkM biopsy	T058	UMLS:C2315740
27491778	744	757	mitochondrial	T017	UMLS:C0026237
27491778	780	796	oxidative stress	T038	UMLS:C0242606
27491778	801	815	blood sampling	T058	UMLS:C0005834
27491778	857	865	subjects	T098	UMLS:C2349001
27491778	880	885	trial	T062	UMLS:C0008976
27491778	894	896	DC	T168	UMLS:C3853217
27491778	912	919	VO2 max	T033	UMLS:C0429693
27491778	1030	1037	placebo	T058	UMLS:C0032042
27491778	1051	1053	DC	T168	UMLS:C3853217
27491778	1083	1086	HDL	T103	UMLS:C0023821
27491778	1120	1133	triglycerides	T103	UMLS:C0041004
27491778	1151	1153	DC	T168	UMLS:C3853217
27491778	1155	1158	SkM	T017	UMLS:C0242692
27491778	1194	1201	protein	T103	UMLS:C0033684
27491778	1213	1217	LKB1	T103	UMLS:C1431123
27491778	1219	1223	AMPK	T103	UMLS:C2350345
27491778	1228	1233	PGC1α	T103	UMLS:C1452082
27491778	1261	1275	phosphorylated	T038	UMLS:C0031715
27491778	1276	1280	AMPK	T103	UMLS:C2350345
27491778	1285	1289	LKB1	T103	UMLS:C1431123
27491778	1305	1330	citrate synthase activity	T038	UMLS:C2258114
27491778	1365	1378	mitochondrial	T017	UMLS:C0026237
27491778	1393	1395	DC	T168	UMLS:C3853217
27491778	1422	1425	SkM	T017	UMLS:C0242692
27491778	1434	1445	glutathione	T103	UMLS:C0017817
27491778	1470	1491	protein carbonylation	T038	UMLS:C1563721
27491778	1549	1556	VO2 max	T033	UMLS:C0429693
27491778	1571	1573	DC	T168	UMLS:C3853217
27491778	1632	1635	SkM	T017	UMLS:C0242692
27491778	1636	1648	mitochondria	T017	UMLS:C0026237
27491778	1668	1684	clinical studies	T062	UMLS:C0008972
27491778	1716	1728	observations	T062	UMLS:C0302523